10-Q – Page 208 – China Stock Advice

EVK [Ever-Glory International,] 10-Q: (Original Filing)

[] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Chief Executive Officer EX-32.1 4 v185028_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yan Guo Chief Finance Officer (Principal Finance Officer) EX-32.2 5 v185028_ex32-2.htm]

By info| 2016-03-02T17:47:18+00:00 May 14th, 2010|Categories: Chinese Stocks, EVK, SEC Original|Tags: 0000943184, 10-Q, 2010-05-14, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

EVK [Ever-Glory International,] 10-Q:

[] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Section 302 of the Sarbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Chief Executive Officer EX-32.1 4 v185028_ex32-1.htm] [OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Yan Guo Chief Finance Officer (Principal Finance Officer) EX-32.2 5 v185028_ex32-2.htm]

By info| 2016-03-02T17:48:21+00:00 May 14th, 2010|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 10-Q, 2010-05-14, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2010 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [ASSETS ACQUISITION AGREEMENT Party A: Shaanxi Biostar Biotech, Ltd. Legal Representative: WANG Ronghua Party B: Xi’an Meipude Bio-Technology Co., Ltd. Legal Representative: SUN Yaomei On March 28, 2010, Party A and Party B again entered into the following agreement concerning Party A’s acquisition of Party B’s assets. A. Party B agrees to transfer all of the technologies and assets of] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Elaine Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 5 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Elaine Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 ex32-2.htm]

By info| 2016-03-03T14:27:06+00:00 May 14th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2010-05-14, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x March 31, 2010

[FORM 10-Q (Mark One) x March 31, 2010 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [ASSETS ACQUISITION AGREEMENT Party A: Shaanxi Biostar Biotech, Ltd. Legal Representative: WANG Ronghua Party B: Xi’an Meipude Bio-Technology Co., Ltd. Legal Representative: SUN Yaomei On March 28, 2010, Party A and Party B again entered into the following agreement concerning Party A’s acquisition of Party B’s assets. A. Party B agrees to transfer all of the technologies and assets of] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Elaine Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 5 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Elaine Zhao Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 ex32-2.htm]

By info| 2016-03-03T14:29:02+00:00 May 14th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2010-05-14, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

EVK [Ever-Glory International,] 10-Q: EVER-GLORY INTERNATIONAL, FORM10-Q INDEX Page Number 3 PART

[EVER-GLORY INTERNATIONAL, FORM10-Q INDEX Page Number 3 PART I. FINANCIAL INFORMATION 4 Item 1. Financial Statements 4ndensednsolidated Balance Sheets of March 31, 2010 (unaudited) and December 31, 2009 4ndensednsolidated Statements ofome andmprehensiveome for the Three Months Ended March 31, 2010 and 2009 (unaudited)] [Section 302 of therbanes-Oxley Act of 2002 I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Ever-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [Section 302 of therbanes-Oxley Act of 2002 I, Yan Guo, certify that: 1. I have reviewed this quarterly report on Form 10-Q ofEver-Glory International,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Edward Yihua Kang Chief Executive Officer v185028_ex32-1.htm 4 EX-32.1] [OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Yan Guo Chief Finance Officer (Principal Finance Officer) v185028_ex32-2.htm 5 EX-32.2]

By info| 2016-02-07T06:14:32+00:00 May 14th, 2010|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 10-Q, 2010-05-14, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x March 31, 2010 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [ASSETS ACQUISITIONREEMENT Party A:Shaanxi Biostar Biotech, Legal Representative:WANG Ronghua Party B: Xian Meipude Bio-Technology Legal Representative:SUN Yaomei On March 28, 2010, Party A and Party Bain entered into the followingreementncerning Party acquisition of Party Bssets. A. Party Brees to transferl of the technologies andsets of Xian Meipude Bio-Technology to Party A, and Party Arees to] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Elaine Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 5 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Elaine Zhao Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 6 EX-32.2]

By info| 2016-02-07T17:26:38+00:00 May 14th, 2010|Categories: BSPM, Chinese Stocks, SEC Original|Tags: 0001418133, 10-Q, 2010-05-14, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x March 31, 2010

[FORM 10-Q (Mark One) x March 31, 2010 For the quarterly period ended: Or For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, Maryland 20-8747899 (State or other jurisdiction oforporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province Peoples Republic of China] [ASSETS ACQUISITIONREEMENT Party A:Shaanxi Biostar Biotech, Legal Representative:WANG Ronghua Party B: Xian Meipude Bio-Technology Legal Representative:SUN Yaomei On March 28, 2010, Party A and Party Bain entered into the followingreementncerning Party acquisition of Party Bssets. A. Party Brees to transferl of the technologies andsets of Xian Meipude Bio-Technology to Party A, and Party Arees to] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION I, Elaine Zhao, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Ronghua Wang Chief Executive Officer ex32-1.htm 5 EX-32.1] [CERTIFICATION (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany at thetes and for the periods indicated. Elaine Zhao Chief Financial Officer (Principal Financial and Accounting Officer) ex32-2.htm 6 EX-32.2]

By info| 2016-02-07T17:27:30+00:00 May 14th, 2010|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: 0001418133, 10-Q, 2010-05-14, 2834, BSPM, PHARMACEUTICAL PREPARATIONS|0 Comments

SORL [SORL Auto Parts] 10-Q: (Original Filing)

[] [Certification of Chief Executive Officer of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Certification of Principal Accounting Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Dated: May 14, 2010 Xiao Ping Zhang Chief Executive Officer Zong Yun Zhou Chief Financial Officer EX-32.1 4 v184597_ex32-1.htm]

By info| 2016-03-26T23:50:56+00:00 May 14th, 2010|Categories: Chinese Stocks, SEC Original, SORL|Tags: 0000714284, 10-Q, 2010-05-14, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments

CHLN [China Housing & Land Development] 10-Q: (Original Filing)

[] [CERTIFICATIONS I, Xiaohong Feng, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Housing & Land Development, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [CERTIFICATIONS I, Cangsang Huang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China Housing & Land Development, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Xiaohong Feng (Chief Executive Officer) EX-32.1 5 v184861_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 1) 2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: May 14, 2010 Cangsang Huang Chief Financial Officer EX-32.2 6 v184861_ex32-2.htm]

By info| 2016-03-29T12:33:10+00:00 May 14th, 2010|Categories: Chinese Stocks, CHLN, SEC Original|Tags: 0001303330, 10-Q, 1520, 2010-05-14, CHLN, GEN BUILDING CONTRACTORS - RESIDENTIAL BUILDINGS|0 Comments

SORL [SORL Auto Parts] 10-Q:

[] [Certification of Chief Executive Officer of the Sarbanes-Oxley Act of 2002 I, Xiao Ping Zhang, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [Certification of Principal Accounting Officer of the Sarbanes-Oxley Act of 2002 I, Zong Yun Zhou, certify that: 1. I have reviewed this Form 10-Q of SORL AUTO PARTS, INC.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in] [CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Dated: May 14, 2010 Xiao Ping Zhang Chief Executive Officer Zong Yun Zhou Chief Financial Officer EX-32.1 4 v184597_ex32-1.htm]

By info| 2016-03-26T23:52:20+00:00 May 14th, 2010|Categories: Chinese Stocks, SORL, Webplus ver|Tags: 0000714284, 10-Q, 2010-05-14, 3714, MOTOR VEHICLE PARTS and ACCESSORIES, SORL|0 Comments